Transcranial pulse stimulation in the treatment of mild neurocognitive disorders

Abstract Objective There are limited effectiveness and potential side effects of existing pharmacological approach in treating mild neurocognitive disorder (NCD). Transcranial pulse stimulation (TPS) applies repetitive single high‐pressure ultrashort shockwave pulses to stimulate the brain, which has been shown to effectively improve cognition in major NCD. However, the effectiveness of TPS in mild NCD patients remained unknown. This study aims to assess the effectiveness and tolerability of TPS with neuro‐navigation in old‐age adults with mild NCD by both clinical and biochemical assessments. Methods An open‐label study recruited older adults with mild NCD to receive neuro‐navigated TPS intervention for two weeks with three sessions per week. Assessments included detailed cognitive assessments, APOE genotype, and brain‐derived neurotrophic factor (BDNF). Results Nineteen participants (12 females and 7 males) completed the whole TPS interventions with no serious adverse effects reported. Repeated measures ANOVA showed statistically significant effects of time on HK‐MoCA ( F (3, 54) = 4.99, P = 0.004), 30‐sec interval of Verbal Fluency Test ( F (3, 54) = 2.94, P = 0.041), Stroop interference ( F (3, 54) = 3.46, P = 0.023), and Chinese IADL ( F (3, 54) = 2.78, P = 0.050) after receiving the intervention. Bonferroni post hoc comparisons on HK‐MoCA showed a significant improvement after intervention. There was no significant change in serum BDNF level. Interpretation TPS has brought significant improvement in cognition of elderly with mild NCD. It has a great potential to delay the deterioration of cognition in older adults. The long‐term effect of TPS in cognition would benefit from further large‐scale, randomized, sham‐controlled trials.